 SAN DIEGO--BUSINESS WIRE--Odonate Therapeutics, Inc. NASDAQ: ODT, a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced that it will host a virtual Investor and Analyst Event on Friday, December 11, 2020, at 1:00 p.m. CT 2:00 p.m. ET. The event will follow the presentation of the results of CONTESSA, a Phase 3 study of tesetaxel in patients with metastatic breast cancer, at the 2020 SA 